Posted on December 30, 2024December 30, 2024 Living Systematic Review on safety of Chikungunya vaccines now available In collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, SPEAC's Special Populations...
Posted on December 11, 2024January 16, 2025 Validating a proposed case definition for Vaccine-Induced Immune Thrombocytopenia and Thrombosis Over time, the need to revisit and refine public health concepts becomes apparent to ensure they remain accurate and relevant. T...
Posted on December 3, 2024January 16, 2025 Report of a SPEAC webinar 22 September 2023: Sensorineural hearing loss, Lassa virus disease and vaccines. Lassa virus (LASV), a member of the Arenavirus family, remains a critical public health challenge in West Africa, with the Nigeria...